United Therapeutics (UTHR) Up 31% On Big Profits
United Therapeutics (UTHR) is up 31% to a new 52-week high at $89. The company had a home run quarter. Total revenues for the third quarter of 2007 were $59.0 million, up 46% from $40.4 million for the third quarter…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
United Therapeutics (UTHR) is up 31% to a new 52-week high at $89.
The company had a home run quarter. Total revenues for the third quarter of 2007 were $59.0 million, up 46% from $40.4 million for the third quarter of 2006. Net income for the third quarter of 2007 was $14.8 million, or $0.70 per basic share, up 74% from $8.5 million, or $0.37 per basic share, in the third quarter of 2006.
Cardiovascular product revenue rose almost 90%. This segment is over half of the company’s revenue.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.